Market Overview:
The global estradiol test kit market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of estrogen-related diseases, rising awareness about early diagnosis and treatment, and technological advancements in estradiol testing kits. The global estradiol test kit market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into time-resolved immunofluorescence assay (TRIFA) and chemiluminescence immunoassay (CLIA). The TRIFA segment is expected to account for a larger share of the global estradiol test kit market in 2018 owing to its high accuracy and sensitivity. On the basis of application, the market is divided into hospital laboratories and clinics laboratories.
Product Definition:
An estradiol test kit is a device used to measure the amount of estradiol in a person's blood. Estradiol is a hormone produced by the ovaries that plays an important role in female reproduction. The level of estradiol in a woman's blood can vary throughout her menstrual cycle and may be different depending on her age. A high level of estradiol can indicate that a woman is experiencing early menopause or ovarian cancer. A low level of estradiol may indicate problems with ovulation or infertility.
Time-resolved Immunofluorescence:
Time-resolved immunofluorescence (TRIF) is a method to study cell biology by using antibodies and fluorescent dyes. It's an advanced form of fluorescence microscopy that allows real-time observation of cellular processes such as protein turnover, membrane traffic, and signaling.
Chemiluminescence Immunoassay:
Chemiluminescence immunoassay (CLIA) is a technique used for the quantitative determination of small molecules, such as estradiol, progesterone, testosterone and thyroid hormones in biological fluids like serum, plasma or urine. It utilizes light energy from a source called chemiluminescent reaction to detect the target analyte.
Application Insights:
The global estradiol test kit market is segmented based on application as hospital, clinic or home testing. The hospital application dominated the overall market in terms of revenue in 2017 due to high usage rate and large number of tests performed annually. This is attributed to growing awareness about various benefits associated with hormonal imbalance and rising prevalence of target diseases across the globe. According to a study published by NCBI, it has been estimated that around 1/3rd women population suffers from some form of menopausal symptoms every year while another 1/10th women population experiences menopause like symptoms every two years. Thus, increasing incidence rates for premenstrual syndrome (PMS) & menopausal symptoms are boosting product demand globally.
Clinic applications are expected to witness lucrative growth over the forecast period owing to rising awareness programs conducted by various organizations such as International Menopause Society (IMS), American College of Obstetricians and Gynecologists (ACOG), etc.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of pharmaceutical companies and increased healthcare expenditure. Moreover, increasing awareness about hormonal disorders among women is also expected to drive regional growth over the forecast period. Asia Pacific is expected to grow at a lucrative CAGR during the forecast period due to rising disposable income and improving healthcare infrastructure in emerging countries such as China, India, Thailand, Malaysia and Indonesia. Furthermore, growing demand for estradiol tests from these regions coupled with untapped opportunities are some factors that can be attributed towards future growth prospects for this market.
In addition there are several upcoming conferences such as The Society For Endocrinology annual meeting scheduled in 2018 which will provide an opportunity for industry players to make their presence felt along with an opportunity for new players enter this highly competitive arena.
Growth Factors:
- Increasing awareness about the benefits of early diagnosis and treatment of estrogen-related health conditions in women.
- Growing demand for estradiol test kits from clinics, hospitals, and other diagnostic centers.
- Rising prevalence of estrogen-related health conditions in women across the globe.
- Technological advancements in estradiol test kit manufacturing that are helping to reduce the overall cost of diagnosis and treatment procedures related to estrogen imbalance disorders in women patients 5 Increased focus on preventive healthcare among women population is also expected to fuel demand for estradiol test kits over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Estradiol Test Kit Market Research Report
By Type
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
By Application
Hospital, Clinic
By Companies
Easydiagnosis, Chivd, BGI, Bioscience, Daan, Fujirebio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
155
Number of Tables & Figures
109
Customization Available
Yes, the report can be customized as per your need.
Global Estradiol Test Kit Market Report Segments:
The global Estradiol Test Kit market is segmented on the basis of:
Types
Time-resolved Immunofluorescence, Chemiluminescence Immunoassay
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Easydiagnosis
- Chivd
- BGI
- Bioscience
- Daan
- Fujirebio
Highlights of The Estradiol Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Time-resolved Immunofluorescence
- Chemiluminescence Immunoassay
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Estradiol Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Estradiol Test Kit is a home pregnancy test that measures the level of estradiol in your urine.
Some of the major players in the estradiol test kit market are Easydiagnosis, Chivd, BGI, Bioscience, Daan, Fujirebio.
The estradiol test kit market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Estradiol Test Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Estradiol Test Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Estradiol Test Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Estradiol Test Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Estradiol Test Kit Market Size & Forecast, 2020-2028
4.5.1 Estradiol Test Kit Market Size and Y-o-Y Growth
4.5.2 Estradiol Test Kit Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Time-resolved Immunofluorescence
5.2.2 Chemiluminescence Immunoassay
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Estradiol Test Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Estradiol Test Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Time-resolved Immunofluorescence
9.6.2 Chemiluminescence Immunoassay
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Time-resolved Immunofluorescence
10.6.2 Chemiluminescence Immunoassay
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Time-resolved Immunofluorescence
11.6.2 Chemiluminescence Immunoassay
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Time-resolved Immunofluorescence
12.6.2 Chemiluminescence Immunoassay
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Time-resolved Immunofluorescence
13.6.2 Chemiluminescence Immunoassay
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Estradiol Test Kit Market: Competitive Dashboard
14.2 Global Estradiol Test Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Easydiagnosis
14.3.2 Chivd
14.3.3 BGI
14.3.4 Bioscience
14.3.5 Daan
14.3.6 Fujirebio
